Follow this preprint
Targeting ATP2B1 impairs PI3K/Akt/Fox-O3 signaling and reduces SARS-COV-2 replication in vivo
Pasqualino de Antonellis, Veronica Ferrucci, Francesca Bibbo, Fathemeh Asadzadeh, Francesca Gorini, Angelo Boccia, Carmen Sorice, Roberto Siciliano, Roberta Russo, Immacolata Andolfo, Vito Alessandro Lasorsa, Sueva Cantalupo, Giovanni Paolella, Giovanna Fusco, Maurizio Viscardi, Sergio Brandi, Bianca Maria Pierri, Pellegrino Cerino, Vittoria Monaco, Dong-Rac choi, Jae-Ho Cheong, Maria Monti, Achille Iolascon, Stefano Amente, Mario Capasso, Hong-Yeoul Kim, View ORCID ProfileMassimo Zollo
doi: https://doi.org/10.1101/2022.09.02.22279542
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Pasqualino de Antonellis
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Veronica Ferrucci
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Francesca Bibbo
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Fathemeh Asadzadeh
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Francesca Gorini
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Angelo Boccia
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Carmen Sorice
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Roberto Siciliano
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
Roberta Russo
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Immacolata Andolfo
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Vito Alessandro Lasorsa
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Sueva Cantalupo
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Giovanni Paolella
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Giovanna Fusco
3Istituto Zooprofilattico Sperimentale del Mezzogiorno, Naples, 80055, Italy
Maurizio Viscardi
3Istituto Zooprofilattico Sperimentale del Mezzogiorno, Naples, 80055, Italy
Sergio Brandi
3Istituto Zooprofilattico Sperimentale del Mezzogiorno, Naples, 80055, Italy
Bianca Maria Pierri
3Istituto Zooprofilattico Sperimentale del Mezzogiorno, Naples, 80055, Italy
Pellegrino Cerino
3Istituto Zooprofilattico Sperimentale del Mezzogiorno, Naples, 80055, Italy
Vittoria Monaco
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
4Department of Chemical Sciences, University ‘Federico II’ University of Naples, Naples 80125, Italy.
Dong-Rac choi
6HAIM BIO Co. Ltd, Industrial Park, Korea University, Seoul, South Korea
5Department of Surgery, Yonsei University College of Medicine, Seoul, Korea
Jae-Ho Cheong
6HAIM BIO Co. Ltd, Industrial Park, Korea University, Seoul, South Korea
Maria Monti
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
4Department of Chemical Sciences, University ‘Federico II’ University of Naples, Naples 80125, Italy.
Achille Iolascon
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Stefano Amente
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Mario Capasso
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
Hong-Yeoul Kim
6HAIM BIO Co. Ltd, Industrial Park, Korea University, Seoul, South Korea
Massimo Zollo
1CEINGE Biotecnologie Avanzate, Naples, 80145, Italy
2Dipartimento di Medicina Molecolare e Biotecnologie Mediche (DMMBM), ‘Federico II’ University of Naples, Naples, 80131, Italy
7DAI Medicina di Laboratorio e Trasfusionale, ‘Federico II’ University of Naples, 80131 Naples, Italy

Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Posted September 06, 2022.
Targeting ATP2B1 impairs PI3K/Akt/Fox-O3 signaling and reduces SARS-COV-2 replication in vivo
Pasqualino de Antonellis, Veronica Ferrucci, Francesca Bibbo, Fathemeh Asadzadeh, Francesca Gorini, Angelo Boccia, Carmen Sorice, Roberto Siciliano, Roberta Russo, Immacolata Andolfo, Vito Alessandro Lasorsa, Sueva Cantalupo, Giovanni Paolella, Giovanna Fusco, Maurizio Viscardi, Sergio Brandi, Bianca Maria Pierri, Pellegrino Cerino, Vittoria Monaco, Dong-Rac choi, Jae-Ho Cheong, Maria Monti, Achille Iolascon, Stefano Amente, Mario Capasso, Hong-Yeoul Kim, Massimo Zollo
medRxiv 2022.09.02.22279542; doi: https://doi.org/10.1101/2022.09.02.22279542
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (420)
- Allergy and Immunology (744)
- Anesthesia (217)
- Cardiovascular Medicine (3204)
- Dermatology (270)
- Emergency Medicine (475)
- Epidemiology (13203)
- Forensic Medicine (19)
- Gastroenterology (885)
- Genetic and Genomic Medicine (5032)
- Geriatric Medicine (469)
- Health Economics (770)
- Health Informatics (3166)
- Health Policy (1121)
- Hematology (419)
- HIV/AIDS (997)
- Medical Education (467)
- Medical Ethics (125)
- Nephrology (512)
- Neurology (4778)
- Nursing (253)
- Nutrition (707)
- Oncology (2460)
- Ophthalmology (698)
- Orthopedics (275)
- Otolaryngology (335)
- Pain Medicine (318)
- Palliative Medicine (89)
- Pathology (527)
- Pediatrics (1272)
- Primary Care Research (545)
- Public and Global Health (7340)
- Radiology and Imaging (1660)
- Respiratory Medicine (961)
- Rheumatology (471)
- Sports Medicine (413)
- Surgery (532)
- Toxicology (68)
- Transplantation (227)
- Urology (198)